Deferasirox

CAS No. 201530-41-8

Deferasirox( ICL670A )

Catalog No. M13141 CAS No. 201530-41-8

An oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 55 In Stock
25MG 71 In Stock
50MG 107 In Stock
100MG 156 In Stock
500MG 386 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Deferasirox
  • Note
    Research use only, not for human use.
  • Brief Description
    An oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.
  • Description
    An oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ICL670A
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    iron
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    201530-41-8
  • Formula Weight
    373.3615
  • Molecular Formula
    C21H15N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(O)C1=CC=C(N2N=C(C3=CC=CC=C3O)N=C2C4=CC=CC=C4O)C=C1
  • Chemical Name
    Benzoic acid, 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sobbe A, et al. J Gastroenterol Hepatol. 2015 Mar;30(3):638-45. 2. Kim JL, et al. Acta Haematol. 2011;126(4):241-5. 3. Lee DH, et al. Exp Hematol. 2013 Jun;41(6):539-46.
molnova catalog
related products
  • (S)-HH2853

    (S)-HH2853 is a potent dual inhibitor of EZH1 and EZH2, inhibiting EZH2_Y641F with an IC50 of <100 nM.(S)-HH2853 has potential antitumor activity and can be used in the study of autoimmune diseases.

  • NMS-P937

    NMS-P937 (NMS1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is with IC50 of 2 nM. The specificity of NMS-P937 forPLK1 is 5000-fold higher over PLK2/PLK3.

  • Cyclen

    Cyclen is a macrocycle capable of selectively binding cations that used as a ligand in chemistry for instance with chemicals used in MRI contrast agents.